Debbe McCall/researchgate.net
Aug 26, 2026, 22:59
Debbe McCall: Should Frail Elderly Patients Stable on Warfarin Switch to DOACs?
Debbe McCall, Owner of TwitterMed LLC, Patient Representative to the Cardiac Drug and Device Advisory Committees at FDA, shared a post on LinkedIn about a recent article by So-Ryoung Lee and Eue-Keun Choi, published in European Heart Journal, adding:
“Reconsidering routine switching from warfarin to direct oral anticoagulants in frail elderly patients with atrial fibrillation stable on warfarin”
Title: Reconsidering routine switching from warfarin to direct oral anticoagulants in frail elderly patients with atrial fibrillation stable on warfarin
Authors: So-Ryoung Lee, Eue-Keun Choi
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests